Development of the symptoms and impacts questionnaire for Crohn's disease and ulcerative colitis-Reference-Cited by-同舟云学术

Development of the symptoms and impacts questionnaire for Crohn's disease and ulcerative colitis

Published:2020-04-21 Issue:11 Volume:51 Page:1047-1066
ISSN:0269-2813
Container-title:Alimentary Pharmacology & Therapeutics
language:en
Short-container-title:Aliment Pharmacol Ther

Author:

Dulai Parambir S.¹²^ORCID,Jairath Vipul¹³⁴^ORCID,Khanna Reena¹³,Ma Christopher¹⁵^ORCID,McCarrier Kelly P.⁶,Martin Mona L.⁷,Parker Claire E.¹^ORCID,Morris Joan¹,Feagan Brian G.¹³⁴^ORCID,Sandborn William J.¹²^ORCID

Affiliation:

1. Robarts Clinical Trials Inc.; London ON Canada

2. Division of Gastroenterology; University of California, San Diego; La Jolla CA USA

3. Department of Medicine; University of Western Ontario; London ON Canada

4. Department of Epidemiology and Biostatistics; University of Western Ontario; London ON Canada

5. Division of Gastroenterology and Hepatology; Departments of Medicine and Community Health Sciences; University of Calgary; Calgary AB Canada

6. Patient-Centered Outcomes Center of Excellence; Pharmerit International; Bethesda MD USA

7. Evidera; Seattle WA USA

Funder

Gilead Sciences

Pfizer

AbbVie

Robarts Clinical Trials Inc

Publisher

Wiley

Subject

Pharmacology (medical),Gastroenterology,Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/apt.15726/fullpdf

Reference30 articles.

1. The expanding therapeutic armamentarium for inflammatory bowel disease: how to choose the right drug[s] for our patients?;Hindryckx;J Crohns Colitis,2018

2. Efficient early drug development for ulcerative colitis;Khanna;Gastroenterology,2016

3. Patient-reported outcome measures for use in clinical trials and clinical practice in inflammatory bowel diseases: a systematic review;De Jong;Clin Gastroenterol Hepatol,2018

4. A new measure of health status for clinical trials in inflammatory bowel disease;Guyatt;Gastroenterology,1989

5. European Medicines Agency Guideline on the development of new medicinal products for the treatment of Crohn's disease https://www.ema.europa.eu/documents/scientific-guideline/guideline-development-new-medicinal-products-treatment-crohns-disease-revision-2_en.pdf

Cited by 38 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Content Validity and Psychometric Evaluation of the Crohn’s Symptom Severity (CSS) Questionnaire in Patients with Moderately to Severely Active Crohn’s Disease;Advances in Therapy;2024-08-06

2. RESULTADOS A LONGO PRAZO DA COLECTOMIA EM PACIENTES COM DOENÇA DE CROHN: UMA REVISÃO SISTEMÁTICA;Revista Contemporânea;2024-07-09

3. The Future of Clinical Trials in Inflammatory Bowel Disease;Clinical Gastroenterology and Hepatology;2024-07

4. The Clinical Course of Bowel Urgency Severity Among Patients with Inflammatory Bowel Disease—A Real-World Study;Drugs - Real World Outcomes;2024-06-15

5. Insights into disability and psycho-social care of patients with inflammatory bowel disease;Frontiers in Medicine;2024-05-28